Thyroid Hormone Receptor, alpha (THRA) (C-Term) Peptide
Quick Overview for Thyroid Hormone Receptor, alpha (THRA) (C-Term) Peptide (ABIN985068)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- MSTDRSGLLC VDKIEKSQEA YLLAFEHYVN HRKHNIPHFW PKLLMKVTDL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Thra Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- THRA (Thyroid Hormone Receptor, alpha (THRA))
-
Background
-
Thra binds the promoter of the Na+/H+ exchanger NHE1 and mediates thyroid hormone induced transcriptional activation.
Alias Symbols: ERBA1, Thra1
Protein Interaction Partner: PIK3R1,Pik3r1
Protein Size: 492 -
Molecular Weight
- 55 kDa
-
Gene ID
- 81812
-
NCBI Accession
- NM_001017960, NP_001017960
-
UniProt
- P63059
Target
-